Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection
Antonio Olea, Janet Grochowski, Anne F. Luetkemeyer, et al.
Integrated Pharmacy Research and Practice (2018) Vol. Volume 7, pp. 105-111
Open Access | Times Cited: 25

Showing 25 citing articles:

Risk factors for infective endocarditis and serious injection related infections among people who inject drugs in Los Angeles, CA and Denver, CO
Siddhi S. Ganesh, Jesse L. Goldshear, Patricia P. Wilkins, et al.
Drug and Alcohol Dependence (2025) Vol. 269, pp. 112588-112588
Closed Access
Common Bacterial Infections in Persons Who Inject Drugs
Michael P. Lorenzo, Kathleen K. Adams, Seth T. Housman
Medicines (2025) Vol. 12, Iss. 2, pp. 8-8
Open Access
Effect of pharmacist care on clinical outcomes among people living with HIV/AIDS: A systematic review and meta-analysis
Ali Ahmed, Juman Abdulelah Dujaili, Inayat Ur Rehman, et al.
Research in Social and Administrative Pharmacy (2021) Vol. 18, Iss. 6, pp. 2962-2980
Closed Access | Times Cited: 26
Pharmacist-Involved Antiretroviral Stewardship Programs in People Living with HIV/AIDS: A Systematic Review
Ali Ahmed, Maria Tanveer, Juman Abdulelah Dujaili, et al.
AIDS Patient Care and STDs (2023) Vol. 37, Iss. 1, pp. 31-52
Closed Access | Times Cited: 10
Expanding Hepatitis C Virus Care and Cure: National Experience Using a Clinical Pharmacist–Driven Model
David E. Koren, Autumn D. Zuckerman, Robyn Teply, et al.
Open Forum Infectious Diseases (2019) Vol. 6, Iss. 7
Open Access | Times Cited: 29
‘Treat my whole person, not just my condition’: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs
Judith I. Tsui, Michael P. Barry, Elizabeth J. Austin, et al.
Addiction Science & Clinical Practice (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 20
Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs
Elizabeth J. Austin, Alexander J. Gojic, Elenore P. Bhatraju, et al.
International Journal of Drug Policy (2022) Vol. 111, pp. 103924-103924
Open Access | Times Cited: 9
Outcomes of a Pharmacist-Led Hepatitis C Virus Treatment Program in an Urban Safety-Net Health System, Chicago, 2017-2019
Bijou R. Hunt, Hollyn Cetrone, Sharon Sam, et al.
Public Health Reports (2021) Vol. 137, Iss. 4, pp. 702-710
Open Access | Times Cited: 11
Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs
J.I. Tsui, Alex J. Gojic, Kerry A. Pierce, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 10, pp. 100213-100213
Open Access | Times Cited: 4
Understanding Adverse Drug Effects and The Clinical Pharmacist's Role in Their Management
Farid Ahmad Tanin
Journal of Natural Science Review (2024) Vol. 2, Iss. 4, pp. 1-35
Closed Access | Times Cited: 1
Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United States
R. Chris Rathbun, Spencer H. Durham, Kevin C. Farmer, et al.
Currents in Pharmacy Teaching and Learning (2020) Vol. 12, Iss. 8, pp. 910-917
Closed Access | Times Cited: 11
Prescription cannabidiol for seizure disorder management: Initial drug-drug interaction management by specialty pharmacists
Holly Dial, Wendi Owens, Josh DeClercq, et al.
American Journal of Health-System Pharmacy (2022) Vol. 79, Iss. 18, pp. 1592-1598
Closed Access | Times Cited: 7
The Role of the Clinical Pharmacist in the Management of People Living with HIV in the Modern Antiretroviral Era
Lucas Hill, Craig Ballard, Edward R. Cachay
Aids Reviews (2019) Vol. 21, Iss. 4
Open Access | Times Cited: 10
Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
Autumn D. Zuckerman, Andrew Douglas, Kristen Whelchel, et al.
PLoS ONE (2019) Vol. 14, Iss. 11, pp. e0225434-e0225434
Open Access | Times Cited: 9
Exploring Australian pharmacists’ perceptions and attitudes towards dispensing HIV medicines in the community setting
Judith Singleton, Esther Lau, Lisa Nissen
Journal of Pharmacy Practice and Research (2021) Vol. 51, Iss. 3, pp. 238-246
Open Access | Times Cited: 4
Attitudes toward pharmacy‐based HCV/HIV testing among people who use drugs in rural Kentucky
Michelle Duong, Chris Delcher, Patricia R. Freeman, et al.
The Journal of Rural Health (2021) Vol. 38, Iss. 1, pp. 93-99
Open Access | Times Cited: 3
Hepatitis C virus micro‐elimination within a clinic for people with HIV: challenges in the home stretch
Jaklin Hanna, Jihan Sufian, Jin‐Suck Suh, et al.
HIV Medicine (2022) Vol. 23, Iss. 7, pp. 801-806
Closed Access | Times Cited: 2
Impact of interplay between autophagy and interferon-alpha in HCV and HCV/HIV infection
B. LAJEVARDI, Taravat Bamdad, Hamzeh Choobin, et al.
Acta Virologica (2019) Vol. 63, Iss. 02, pp. 235-239
Open Access | Times Cited: 2
A survey of pharmacists' roles in gastroenterology and hepatology
David Choi, Shivani Patel, Itishree Trivedi, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2021) Vol. 4, Iss. 10, pp. 1280-1286
Closed Access | Times Cited: 2
Pain Physicians’ Attitudes and Experiences Regarding Clinical Pharmacy Services in China: A National Cross-Sectional Survey
Wangjun Qin, Siyu Yuan, Li Zhao, et al.
Journal of Multidisciplinary Healthcare (2023) Vol. Volume 16, pp. 21-29
Open Access
Impacts of Pharmacists-Managed Outpatient Clinic in patients with Hepatitis C virus infection: A Retrospective Study in China
Can Huang, Aiping Gao, Cuixia Guo, et al.
Research Square (Research Square) (2023)
Open Access
Impact of an Interprofessional HIV Quality Improvement Team on Patient Care and Resident Learning Opportunities
Marilyn K. Sauk, Kento Sonoda, Carly Gabriel, et al.
PRiMER (2023) Vol. 7
Open Access
ADHERENCE, ADVERSE DRUG REACTION AND EFFECTIVENESS OF THE HEPATITIS C CHRONIC TREATMENT
Karin Hepp Schwambach, Carine Raquel Blatt
Revista Contexto & Saúde (2020) Vol. 20, Iss. 38, pp. 86-93
Open Access
Retrospective Evaluation on Patient Screening and Counseling Service on Direct-acting Antivirals Against Hepatitis C
Bob Ka Him Wong, Gary Chung Hong Chong
Asia Pacific Journal of Health Management (2020) Vol. 15, Iss. 2, pp. S99-103
Open Access
Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital
Mi Seon Park, Young-Mo Yang, Ki Hyun Park, et al.
Korean Journal of Clinical Pharmacy (2022) Vol. 32, Iss. 3, pp. 191-203
Open Access
Page 1

Scroll to top